Literature DB >> 10594501

Clinicopathological study of intrapelvic cancer spread to the iliac area in lower rectal adenocarcinoma by serial sectioning.

H Ueno1, C Yamauchi, K Hase, T Ichikura, H Mochizuki.   

Abstract

BACKGROUND: The role of iliac lymphadenectomy in surgery for rectal cancer remains unknown. Detailed clinicopathological data on lateral cancer extension may be needed to determine the true role of this procedure.
METHODS: Seventy consecutive patients with low rectal cancer who underwent systematic iliac lymphadenectomy between 1991 and 1995 were reviewed. The iliac area was divided into five regions: (1) middle rectal root, (2) internal iliac, (3) obturator, (4) common iliac and (5) external iliac. Iliac lymph nodes that were cancer-free based on conventional pathological examination were serially sectioned at 100-microm intervals and re-examined for occult microscopic involvement.
RESULTS: Occult microscopic foci were detected in five (7 per cent) of the 70 patients, and the overall incidence of lateral cancer spread was 24 per cent (17 of 70). Among patients without other sites of distant metastasis or circumferential involvement of the margin, the 5-year survival rate of those with lateral spread was 35 per cent. Although the prognosis of patients with cancer involving multiple iliac regions was poor, three of six patients with metastasis to only a single region were alive without disease at 3 years.
CONCLUSION: Surgeons should be aware of the possibility of localized lateral spread, including microscopic metastasis, when determining the optimum procedure for iliac lymphadenectomy in patients with rectal cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10594501     DOI: 10.1046/j.1365-2168.1999.01271.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

1.  Morphological characteristics of lateral pelvic lymph nodes in rectal carcinoma.

Authors:  Hiroyoshi Matsuoka; Tadahiko Masaki; Masanori Sugiyama; Yutaka Atomi; Yasuo Ohkura; Atsuhiko Sakamoto
Journal:  Langenbecks Arch Surg       Date:  2007-03-23       Impact factor: 3.445

2.  Impact of Lateral Pelvic Lymph Node Dissection on the Survival of Patients with T3 and T4 Low Rectal Cancer.

Authors:  Heita Ozawa; Kenjiro Kotake; Miki Hosaka; Akira Hirata; Kenichi Sugihara
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

3.  Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection.

Authors:  Hideki Ueno; Hidetaka Mochizuki; Yojiro Hashiguchi; Megumi Ishiguro; Masayoshi Miyoshi; Yoshiki Kajiwara; Taichi Sato; Hideyuki Shimazaki; Kazuo Hase
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

4.  Prognostic determinants of patients with lateral nodal involvement by rectal cancer.

Authors:  H Ueno; H Mochizuki; Y Hashiguchi; K Hase
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

5.  Necessity of external iliac lymph nodes and inguinal nodes radiation in rectal cancer with anal canal involvement.

Authors:  Rong Zheng; YaZhen Zhang; RunFan Chen; Bingjie Guan; YuPing Lin; BiSi Wang; XiaoBo Li; Pan Chi; XiaoPing Chen; BenHua Xu
Journal:  BMC Cancer       Date:  2022-06-14       Impact factor: 4.638

6.  Laparoscopic rectal surgery for middle and lower rectal cancer.

Authors:  Yosuke Fukunaga; Masayuki Higashino; Shinnya Tanimura; Masashi Takemura; Yushi Fujiwara
Journal:  Surg Endosc       Date:  2009-06-11       Impact factor: 4.584

7.  Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors.

Authors:  Shunsuke Tsukamoto; Shin Fujita; Tomohiro Yamaguchi; Seiichiro Yamamoto; Takayuki Akasu; Yoshihiro Moriya; Hirokazu Taniguchi; Tadakazu Shimoda
Journal:  Int J Colorectal Dis       Date:  2008-07-02       Impact factor: 2.571

8.  Case of isolated lateral lymph node recurrence occurring after TME for T1 lower rectal cancer treated with lateral lymph node dissection: report of a case.

Authors:  Toshinori Sueda; Shingo Noura; Masayuki Ohue; Tatsushi Shingai; Shinya Imada; Yoshiyuki Fujiwara; Hiroaki Ohigashi; Masahiko Yano; Yasuhiko Tomita; Osamu Ishikawa
Journal:  Surg Today       Date:  2012-07-26       Impact factor: 2.549

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.